Interleukin-1β Regulates Fat-Liver Crosstalk in Obesity by Auto-Paracrine Modulation of Adipose Tissue Inflammation and Expandability

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Nov, Ori ^a   Shapiro, Hagit ^a   Ovadia, Hilla ^a   Tarnovscki, Tanya ^a   Dvir, Irit ^b   Shemesh, Elad ^a   Kovsan, Julia ^a   Shelef, Ilan ^a,c   Carmi, Yaron ^a   Voronov, Elena ^a   Apte, Ron N ^a   Lewis, Eli ^a   Haim, Yulia ^a   Konrad, Daniel ^d   Bashan, Nava ^a   Rudich, Assaf ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b SAPIR ACADEMIC COLLEGE   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; FAT; FATTY ACID BINDING PROTEIN 4; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PYRUVIC ACID;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CEPBA GENE; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; EX VIVO STUDY; EXPLANT; FABP4 GENE; FAT CONTENT; FATTY LIVER; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE TRANSPORT; GLUT4 GENE; HYPERTROPHY; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; KNOCKOUT MOUSE; LIPID DIET; LIPID LIVER LEVEL; LIPID STORAGE; LIVER CELL; LIVER SIZE; MACROPHAGE; MALE; MARKER GENE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; OBESITY; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PORTAL VEIN BLOOD; PPARG GENE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; WILD TYPE;

ADIPOSE TISSUE; ANIMALS; AUTOCRINE COMMUNICATION; COCULTURE TECHNIQUES; DIET, HIGH-FAT; FATTY LIVER; HEPATOCYTES; INFLAMMATION; INSULIN RESISTANCE; INTERLEUKIN-1BETA; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY;

MUS;

EID: 84872480987     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053626     Document Type: Article

References (47)

1. Moschen AR, Molnar C, Enrich B, Geiger S, Ebenbichler CF, et al. (2011) Adipose and liver expression of interleukin (IL)-1 family members in morbid obesity and effects of weight loss. Mol Med 17: 840-845.
2. Stienstra R, Tack CJ, Kanneganti TD, Joosten LA, Netea MG, (2012) The inflammasome puts obesity in the danger zone. Cell Metab 15: 10-18.
3. Spranger J, Kroke A, Mohlig M, Hoffmann K, Bergmann MM, et al. (2003) Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52: 812-817.
4. Larsen CM, Faulenbach M, Vaag A, Volund A, Ehses JA, et al. (2007) Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 356: 1517-1526.
5. Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, et al. (2011) The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 17: 179-188.
6. Wen H, Gris D, Lei Y, Jha S, Zhang L, et al. (2011) Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol 12: 408-415.
7. Stienstra R, van Diepen JA, Tack CJ, Zaki MH, van de Veerdonk FL, et al. (2011) Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci U S A 108: 15324-15329.
8. Stienstra R, Mandard S, Tan NS, Wahli W, Trautwein C, et al. (2007) The Interleukin-1 receptor antagonist is a direct target gene of PPARalpha in liver. J Hepatol 46: 869-877.
9. McGillicuddy FC, Harford KA, Reynolds CM, Oliver E, Claessens M, et al. (2011) Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis. Diabetes 60: 1688-1698.
10. Stienstra R, Joosten LA, Koenen T, van Tits B, van Diepen JA, et al. (2010) The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab 12: 593-605.
11. Kamari Y, Shaish A, Vax E, Shemesh S, Kandel-Kfir M, et al. (2011) Lack of interleukin-1alpha or interleukin-1beta inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice. J Hepatol 55: 1086-1094.
12. Harman-Boehm I, Bluher M, Redel H, Sion-Vardy N, Ovadia S, et al. (2007) Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab 92: 2240-2247.
13. Bergman RN, Kim SP, Hsu IR, Catalano KJ, Chiu JD, et al. (2007) Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk. Am J Med 120: S3-8; discussion S29-32.
14. Kabir M, Catalano KJ, Ananthnarayan S, Kim SP, Van Citters GW, et al. (2005) Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. Am J Physiol Endocrinol Metab 288: E454-461.
15. Sabio G, Das M, Mora A, Zhang Z, Jun JY, et al. (2008) A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 322: 1539-1543.
16. Wueest S, Rapold RA, Schumann DM, Rytka JM, Schildknecht A, et al. (2010) Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice. J Clin Invest 120: 191-202.
17. Rytka JM, Wueest S, Schoenle EJ, Konrad D, (2011) The portal theory supported by venous drainage-selective fat transplantation. Diabetes 60: 56-63.
18. Konrad D, Rudich A, Schoenle EJ, (2007) Improved glucose tolerance in mice receiving intraperitoneal transplantation of normal fat tissue. Diabetologia 50: 833-839.
19. Shaul ME, Bennett G, Strissel KJ, Greenberg AS, Obin MS, (2010) Dynamic, M2-like remodeling phenotypes of CD11c+ adipose tissue macrophages during high-fat diet-induced obesity in mice. Diabetes 59: 1171-1181.
20. Lagathu C, Yvan-Charvet L, Bastard JP, Maachi M, Quignard-Boulange A, et al. (2006) Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes. Diabetologia 49: 2162-2173.
21. Jager J, Gremeaux T, Cormont M, Le Marchand-Brustel Y, Tanti JF, (2007) Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 148: 241-251.
22. Matsuki T, Horai R, Sudo K, Iwakura Y, (2003) IL-1 plays an important role in lipid metabolism by regulating insulin levels under physiological conditions. J Exp Med 198: 877-888.
23. Suzawa M, Takada I, Yanagisawa J, Ohtake F, Ogawa S, et al. (2003) Cytokines suppress adipogenesis and PPAR-gamma function through the TAK1/TAB1/NIK cascade. Nat Cell Biol 5: 224-230.
24. Cawood TJ, Moriarty P, O'Farrelly C, O'Shea D, (2006) The effects of tumour necrosis factor-alpha and interleukin1 on an in vitro model of thyroid-associated ophthalmopathy; contrasting effects on adipogenesis. Eur J Endocrinol 155: 395-403.
25. Nov O, Kohl A, Lewis EC, Bashan N, Dvir I, et al. (2010) Interleukin-1beta may mediate insulin resistance in liver-derived cells in response to adipocyte inflammation. Endocrinology 151: 4247-4256.
26. Xu H, Barnes GT, Yang Q, Tan G, Yang D, et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112: 1821-1830.
27. Kosteli A, Sugaru E, Haemmerle G, Martin JF, Lei J, et al. (2010) Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J Clin Invest 120: 3466-3479.
28. Persson J, Nilsson J, Lindholm MW, (2008) Interleukin-1beta and tumour necrosis factor-alpha impede neutral lipid turnover in macrophage-derived foam cells. BMC Immunol 9: 70.
29. Mosser DM, Edwards JP, (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969.
30. Shaul ME, Bennett G, Strissel KJ, Greenberg AS, Obin MS, (2010) Dynamic, M2-like Remodeling Phenotypes of CD11c+ Adipose Tissue Macrophages During High Fat Diet-Induced Obesity in Mice. Diabetes 59: 1171-1181.
31. Zeyda M, Farmer D, Todoric J, Aszmann O, Speiser M, et al. (2007) Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int J Obes (Lond) 31: 1420-1428.
32. Guilherme A, Virbasius JV, Puri V, Czech MP, (2008) Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9: 367-377.
33. Fujiki K, Kano F, Shiota K, Murata M, (2009) Expression of the peroxisome proliferator activated receptor gamma gene is repressed by DNA methylation in visceral adipose tissue of mouse models of diabetes. BMC Biol 9: 70.
34. Sniderman AD, Bhopal R, Prabhakaran D, Sarrafzadegan N, Tchernof A, (2007) Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis. Int J Epidemiol 36: 220-225.
35. Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, et al. (2007) Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117: 2621-2637.
36. Trak-Smayra V, Paradis V, Massart J, Nasser S, Jebara V, et al. (2011) Pathology of the liver in obese and diabetic ob/ob and db/db mice fed a standard or high-calorie diet. Int J Exp Pathol 92: 413-421.
37. Persson H, Wallmark H, Ljungars A, Hallborn J, Ohlin M, (2008) In vitro evolution of an antibody fragment population to find high-affinity hapten binders. Protein Eng Des Sel 21: 485-493.
38. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, et al. (2010) NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464: 1357-1361.
39. Rider P, Carmi Y, Guttman O, Braiman A, Cohen I, et al. (2011) IL-1alpha and IL-1beta recruit different myeloid cells and promote different stages of sterile inflammation. J Immunol 187: 4835-4843.
40. Carmi Y, Rinott G, Dotan S, Elkabets M, Rider P, et al. (2011) Microenvironment-derived IL-1 and IL-17 interact in the control of lung metastasis. J Immunol 186: 3462-3471.
41. Horai R, Asano M, Sudo K, Kanuka H, Suzuki M, et al. (1998) Production of mice deficient in genes for interleukin (IL)-1alpha, IL-1beta, IL-1alpha/beta, and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine-induced fever development and glucocorticoid secretion. J Exp Med 187: 1463-1475.
42. Ovadia H, Haim Y, Nov O, Almog O, Kovsan J, et al. (2011) Increased adipocyte S-nitrosylation targets anti-lipolytic action of insulin: relevance to adipose tissue dysfunction in obesity. J Biol Chem 286: 30433-30443.
43. Berry MN, Friend DS, (1969) High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol 43: 506-520.
44. Bloch-Damti A, Potashnik R, Gual P, Le Marchand-Brustel Y, Tanti JF, et al. (2006) Differential effects of IRS1 phosphorylated on Ser307 or Ser632 in the induction of insulin resistance by oxidative stress. Diabetologia 49: 2463-2473.
45. Elgazar-Carmon V, Rudich A, Hadad N, Levy R, (2008) Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding. J Lipid Res 49: 1894-1903.
46. Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, et al. (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 46: 2347-2355.
47. Hao HX, Cardon CM, Swiatek W, Cooksey RC, Smith TL, et al. (2007) PAS kinase is required for normal cellular energy balance. Proc Natl Acad Sci U S A 104: 15466-15471.